# Study of Individualized Therapies Selection for Patients With Metastatic Colorectal Carcinoma According to the Therapeutic

> **NCT01703910** · PHASE2 · COMPLETED · sponsor: **Centro Nacional de Investigaciones Oncologicas CARLOS III** · enrollment: 29 (actual)

## Conditions studied

- Adenocarcinoma of Colon
- Adenocarcinoma of Rectum
- Metastatic Disease

## Interventions

- **DRUG:** Arm A chemotherapy
- **DRUG:** arm B chemotherapy

## Key facts

- **NCT ID:** NCT01703910
- **Lead sponsor:** Centro Nacional de Investigaciones Oncologicas CARLOS III
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2012-11
- **Final completion:** 2014-12
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2015-10-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01703910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01703910, "Study of Individualized Therapies Selection for Patients With Metastatic Colorectal Carcinoma According to the Therapeutic". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01703910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*